fbpx

Thomas Montine, M.D., Ph.D. – Jay Van Andel Seminar Series

 

To be added to the scientific events notification list, please click here.

Loading Events

« All Events

Thomas Montine, M.D., Ph.D. – Jay Van Andel Seminar Series

June 30 @ 12:00 pm

“Synaptopathology in Alzheimer’s and Parkinson’s diseases”

Dr. Montine received his education at Columbia University (BA in Chemistry), the University of Rochester (PhD in Pharmacology), and McGill University (MD and CM). His postgraduate medical training was at Duke University, and he was junior faculty at Vanderbilt University where he was awarded the Thorne Professorship in Pathology. In 2002, Dr. Montine was appointed as the Alvord Endowed Professor in Neuropathology and Director of the Division of Neuropathology at the University of Washington. He was Director of the University of Washington Alzheimer’s Disease Research Center, one of the original 10 Centers in the US, and passed that responsibility to able colleagues.  In 2010, Dr. Montine was appointed Chair of the Department of Pathology at the University of Washington. In 2016, Dr. Montine was appointed Chair of the Department of Pathology at Stanford University and the Stanford Medicine Endowed Professor in Pathology.

Dr. Montine was the 2015 President of the American Association of Neuropathologists, and led or co-led recent NIH initiatives to revise diagnostic guidelines for Alzheimer’s disease (NIA), develop research priorities for the National Alzheimer’s Plan (NINDS and NIA), and develop national research priorities for Parkinson’s Disease (NINDS). He is the founding Director of the Pacific Udall Center, one of 9 NINDS-funded Morris K. Udall Centers of Excellence for Parkinson’s Disease Research, that focuses on a vision for precision health that comprises functional genomics, development of surveillance tools for pre-clinical detection, and discovery of molecularly tailored therapies.

The focus of the Montine Laboratory is on the molecular and biochemical bases of cognitive impairment in aging and neurodegenerative diseases with the goal of defining key pathogenic steps and thereby new therapeutic targets. The Montine Laboratory addresses these prevalent, unmet medical needs through a combination of neuropathology, biomarker development and application early in the course of disease, and experimental studies that test hypotheses concerning specific mechanisms of neuron injury and approaches to neuroprotection.

Speaker Information

Thomas Modine, M.D., Ph.D.
Stanford University School of Medicine

Time & Location

12:00 pm on Zoom

VAI Host: José Brás, Ph.D.

Questions?

For questions, please contact Kim Cousineau at 616.234.5684.

Details

Date:
June 30
Time:
12:00 pm
Event Categories:
,

Venue

Van Andel Institute
333 Bostwick Ave. NE
Grand Rapids, MI 49503 United States